I remember one more though I don't follow it.Cytofab, an anti-TNF-alpha polyclonal antibody fragment entering a single phase III study in 2007 for the treatment of severe sepsis.It is from Protherics and is partnered by AZN. <A HREF="http://www.protherics.com/products/development.aspx" target="_blank">http://www.protherics.com/products/development.aspx</A> Regards, Praveen